Paul Hargreaves
Corporate Officer/Principal bei SPAGO NANOMEDICAL AB
Profil
Paul Hargreaves is currently the Chief Development Officer at Spago Nanomedical AB since 2021.
Prior to this, he worked at LEO Pharma.
A as the Head-Global Clinical Operations & Vice President.
Aktive Positionen von Paul Hargreaves
| Unternehmen | Position | Beginn |
|---|---|---|
| SPAGO NANOMEDICAL AB | Corporate Officer/Principal | 13.09.2021 |
Ehemalige bekannte Positionen von Paul Hargreaves
| Unternehmen | Position | Ende |
|---|---|---|
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SPAGO NANOMEDICAL AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
